Adjuvant Radiation Therapy for Salivary Duct and Epithelial Myoepithelial Salivary Carcinoma.


Journal

Practical radiation oncology
ISSN: 1879-8519
Titre abrégé: Pract Radiat Oncol
Pays: United States
ID NLM: 101558279

Informations de publication

Date de publication:
30 Dec 2023
Historique:
received: 17 12 2023
accepted: 18 12 2023
pubmed: 2 1 2024
medline: 2 1 2024
entrez: 31 12 2023
Statut: aheadofprint

Résumé

Salivary gland cancers are rare in general and salivary duct carcinoma and epithelial myoepithelial carcinomas are rare subtypes. This topic discussion will review the characteristics of these uncommon cancers. Additionally, it will briefly discuss available guidelines for salivary cancers and summarize author opinions on the role of adjuvant radiation therapy for these cases.

Identifiants

pubmed: 38161001
pii: S1879-8500(23)00348-X
doi: 10.1016/j.prro.2023.12.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosures None.

Auteurs

Laura Freedman (L)

Department of Radiation Oncology, University of Miami, Deerfield Beach, Florida. Electronic address: lfreedman@med.miami.edu.

Beth Beadle (B)

Department of Radiation Oncology, Stanford University, Palo Alto, California.

Bhishamajit Chera (B)

Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina.

Jaylou M Velez Torres (JM)

Department of Pathology, University of Miami, Miami, Florida.

Classifications MeSH